Previous close | 4.6800 |
Open | 4.9100 |
Bid | 4.5900 x 300 |
Ask | 4.6600 x 100 |
Day's range | 4.6008 - 4.9830 |
52-week range | 2.0100 - 6.1300 |
Volume | |
Avg. volume | 1,028,548 |
Market cap | 377.072M |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Sutro Biopharma (STRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So...
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.